Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)

Clinical trial NCT01390792 · COMPLETED

Trial details

NCT number: NCT01390792
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Influenza, Human

Start date: 2007-01-01
Primary completion: 2009-02-01
Enrollment: 622

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.